| Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss EN Hamulyák, LJJ Scheres, MC Marijnen, M Goddijn, S Middeldorp Cochrane Database of Systematic Reviews, 2020 | 131 | 2020 |
| A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms EN Hamulyák, JG Daams, FWG Leebeek, BJ Biemond, ... Blood advances 5 (1), 113-121, 2021 | 50 | 2021 |
| Sex matters: practice 5P's when treating young women with venous thromboembolism IM Bistervels, LJJ Scheres, EN Hamulyák, S Middeldorp Journal of Thrombosis and Haemostasis 17 (9), 1417-1429, 2019 | 38 | 2019 |
| Apixaban and dalteparin for the treatment of venous thromboembolism in patients with different sites of cancer G Agnelli, A Muñoz, L Franco, I Mahé, B Brenner, JM Connors, G Gussoni, ... Thrombosis and haemostasis 122 (05), 796-807, 2022 | 35 | 2022 |
| Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases A Leader, EN Hamulyák, BJ Carney, M Avrahami, JJ Knip, S Rozenblatt, ... Blood advances 4 (24), 6291-6297, 2020 | 35 | 2020 |
| Emergencies on direct oral anticoagulants: management, outcomes, and laboratory effects of prothrombin complex concentrate R Bavalia, R Abdoellakhan, HJM Brinkman, MPA Brekelmans, ... Research and practice in thrombosis and haemostasis 4 (4), 569-581, 2020 | 29 | 2020 |
| Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial S Quenby, K Booth, L Hiller, A Coomarasamy, PG de Jong, EN Hamulyák, ... The Lancet 402 (10395), 54-61, 2023 | 24 | 2023 |
| Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome—What is the evidence? EN Hamulyák, LJJ Scheres, M Goddijn, S Middeldorp Journal of Thrombosis and Haemostasis 19 (5), 1174-1185, 2021 | 20 | 2021 |
| Heavy menstrual bleeding on direct factor Xa inhibitors: rationale and design of the MEDEA study EN Hamulyák, HMG Wiegers, LJJ Scheres, BA Hutten, ME de Lange, ... Research and practice in thrombosis and haemostasis 5 (1), 223-230, 2021 | 14 | 2021 |
| Women’s health in The BMJ: a data science history EN Hamulyák, AJ Brockmeier, JD Killas, S Ananiadou, S Middeldorp, ... BMJ open 10 (10), e039759, 2020 | 10 | 2020 |
| Progress of the ALIFE2 study: A dynamic road towards more evidence EN Hamulyák, PG de Jong, LJJ Scheres, LJ Ewington, S Middeldorp, ... Thrombosis research 190, 39-44, 2020 | 10 | 2020 |
| Pregnancy outcomes in women with Budd–Chiari syndrome or portal vein thrombosis–a multicentre retrospective cohort study HMG Wiegers, EN Hamulyák, SE Damhuis, JR van Duuren, ... BJOG: An International Journal of Obstetrics & Gynaecology 129 (4), 608-617, 2022 | 8 | 2022 |
| A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms. Blood Adv 5: 113–121 EN Hamulyák, JG Daams, FWG Leebeek, BJ Biemond, ... | 7 | 2021 |
| Low-molecular-weight heparin versus standard pregnancy care for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an open-label, phase III randomized … S Quenby, K Booth, L Hiller, A Coomarasamy, E Hamulyák, L Scheres, ... Blood 140 (Supplement 2), LBA-5-LBA-5, 2022 | 4 | 2022 |
| OC 54.4 Multinational Cohort Analysis of Intracranial Hemorrhage Outcomes in Patients with Brain Tumors Receiving Anticoagulation (ABC Study) A Leader, E Hamulyák, T Wang, LB Kreuziger, B Carney, A Hoeben, ... Research and Practice in Thrombosis and Haemostasis 7, 2023 | 1 | 2023 |
| Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial EN Hamulyák, HMG Wiegers, BA Hutten, ME de Lange, A Timmermans, ... Research and Practice in Thrombosis and Haemostasis 8 (4), 102448, 2024 | | 2024 |
| Concerns about the ALIFE2 trial–Authors’ reply S Quenby, L Ewington, E Hamulyák, LJ Scheres, M Goddijn, ... The Lancet 403 (10423), 248, 2024 | | 2024 |
| Venous thromboembolism among physically active young adult females M Shapiro, EN Hamulyák, A Leader, R Landau, S Middeldorp, ... Research and practice in thrombosis and haemostasis 7 (8), 102236, 2023 | | 2023 |
| OC 71.4 Management Patterns of Antithrombotics and Outcomes in Patients with Hematological Malignancy and Thrombocytopenia: A Prospective Registry (Matter Study) A Leader, G Spectre, A Chistolini, E Beckers, T Elling, E Beggiato, ... Research and Practice in Thrombosis and Haemostasis 7, 2023 | | 2023 |
| Implementation of a clinical decision-making tool for perioperative management of vitamin K antagonists in patients with atrial fibrillation EN Hamulyák, D Westenberg, C Bresser, S Sissing, M Ruiter, ... Thrombosis Research 228, 200-202, 2023 | | 2023 |
